Multivariate linear regression model evaluating the association between tumor response (RECIST, %) and the following variables : age > 65 y.o. (yes/no), TGR REFERENCE and the Royal Marsden Prognostic from Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1
Authors:
- Stéphane ChampiatSCStéphane Champiat
- Laurent DercleLaurent Dercle
- Samy AmmariSASamy Ammari
- Christophe MassardCMChristophe Massard
- Antoine HollebecqueAHAntoine Hollebecque
- Sophie Postel-VinaySPSophie Postel-Vinay
- Nathalie ChaputNCNathalie Chaput
- Alexander EggermontAEAlexander Eggermont
- Aurélien MarabelleAMAurélien Marabelle
- Jean-Charles SoriaJSJean-Charles Soria
- Charles FertéCFCharles Ferté
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)